Conference Chairs
Sehyun Shin Professor & Director, Korea University |
Chulhee Choi Professor, Korea Advanced Institute of Science and Technology (KAIST); President, ILIAS Biologics Incorporated |
Keynote Speakers
Hyo-Il Jung Professor, Yonsei University |
Yong Song Gho Professor, Pohang University of Science And Technology (POSTECH) |
Jan Lötvall Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles |
Hidetoshi Tahara Deputy Executive Director, Industry-Academia Collaboration; Professor, Department of Cellular and Molecular Biology; Head, The Research Center for Drug development and Biomarker Discovery, Hiroshima University |
In-San Kim Principal Investigator and Professor, Korea Institute Science and Technology/Korea University |
Moran Bercovici Associate Professor, Faculty of Mechanical Engineering; Head, Technion Microfluidic Technologies Laboratory, Technion, Israel Institute of Technology |
|
Dominique PV de Kleijn Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands |
Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas |
Yoon-Kyoung Cho Professor, Biomedical Engineering, Ulsan National Institute of Science & Technology; Group leader, IBS; FRSC, Fellow of Royal Society of Chemistry |
Sai Kiang Lim Research Director, Institute of Medical Biology, A*STAR |
OverviewSelectBIO Microfluidics, Circulating Biomarkers & Exosomes Asia 2020 will be held in Seoul Korea, September 14-15, 2020.
This
conference brings together a focus on technology development as well as
applications for biomarker analysis in cancer, cardiovascular disease
and other disease classes.
The conference focuses heavily on the
various classes of circulating biomarkers and emphasizes the many
technology platforms currently being utilized to interrogate Circulating
Cell-Free DNA (cfDNA), Circulating Tumor Cells (CTCs) and Extracellular
Vesicles (EVs)/Exosomes.
Importantly, this conference brings together technologies in Microfluidics and Lab-on-a-Chip which together are impacting the study of circulating biomarkers such as CTCs, cfDNA and Exosomes/EVs.
The potential of EVs/Exosomes for
Therapeutics Development and Drug Delivery are Presented as well as the
Potential of EVs derived from Stem Cells for Regenerative Medicine.
This
conference also features a showcase of companies involved in the study
of cfDNA, CTCs and Exosomes and technologies in this space.
Korea
is an excellent venue for this Asia/Pacific conference with a very
strong scientific and technology focus and extensive research in this
space plus the excellent conference location in Seoul is accessible from
around the world to maximize networking and partnering activities at
this conference.
|
Agenda Topics- Circulating Biomarker Classes (Circulating Cell-Free DNA, Circulating Tumor Cells, Exosomes)
- Biomarker Cargo
- Technologies for Isolation and Analysis
- Extracellular Vesicles (EVs)/Exosomes
- Classes of Biomarkers
- Engineering, Delivery Vehicles and Therapeutics Development
- Technologies for Isolation, Analysis & Engineering
- Liquid Biopsy Development
- Technologies for Development Utilizing Biofluids
- Microfluidics & Lab-on-a-Chip
- Scope of Applications and Utlilization in Life Science Research
- Technology Platforms
- Utilization for Study of Circulating Biomarkers such as CTCs, Exosomes, cfDNA
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|